MiNK Therapeutics, Inc. (INKT)
NASDAQ·Healthcare·Biotechnology
$10.58
+1.44%
Mkt Cap $55.32M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$35.00
Range $35.00 – $35.00
Implied Upside
+230.8%
Consensus $35.00 vs current $10.58
NASDAQ·Healthcare·Biotechnology
$10.58
+1.44%
Mkt Cap $55.32M
No recent rating data.
Price Target (1 analysts)
$35.00
Range $35.00 – $35.00
+230.8%
Consensus $35.00 vs current $10.58